Phentermine And Topiramate
A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults
VIVUS · Phase 3 · Completed · Enrollment 756
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| VI-0521 Top | 8 participants | n/r | 6 participants | n/r | n/r |
| VI-0521 Mid | 9 participants | n/r | 4 participants | n/r | n/r |
| TPM 46 | 8 participants | n/r | 3 participants | n/r | n/r |
| TPM 92 | 5 participants | n/r | 6 participants | n/r | n/r |
| PHEN 7.5 | 5 participants | n/r | 1 participants | n/r | n/r |
| PHEN 15 | 6 participants | n/r | 4 participants | n/r | n/r |
| Placebo | 5 participants | n/r | 5 participants | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.